The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

The trial was aimed at evaluating the efficacy, safety, and pharmacokinetics of Atumelnant when administered for 12 weeks in ...

The company announced a $350 million public offering on Monday shortly after revealing positive Phase II results for its ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on ...

Intraductal proliferations of mammary epithelium of the breast form a spectrum that begins with intraductal hyperplasia without atypia (also known as conventional ductal hyperplasia), continues with ...

A month after Neurocrine Biosciences’ drug crinecerfont renewed analysts’ hopes of its blockbuster potential by acing a phase 3 study in adults with hyperplasia, the therapy has now scored another win ...

Endometrial hyperplasia (EH) is a condition in which the innermost lining of the uterus, or endometrium, undergoes thickening usually as a result of exposure to estrogen unbalanced by progesterone. It ...

Endometrial hyperplasia refers to the thickening of the endometrium. This is the layer of cells that line the inside of your uterus. When your endometrium thickens, it can lead to unusual bleeding.

This page lists all known medications that could potentially lead to 'Endometrial hyperplasia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Drug-induced gingival hyperplasia usually arises from the use of certain medications. The main drug classes involved in this condition are anticonvulsants, immunosuppressants, and calcium channel ...

BOSTON and YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- Butterfly Medical, developer of a proprietary non-surgical solution for benign prostatic hyperplasia (BPH), today announced the successful ...